Gilead Sciences, Inc.
GILD
$148.95
$5.183.60%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,672.92% | 6,336.51% | 498.77% | 1,129.90% | -91.53% |
| Total Depreciation and Amortization | -0.25% | 0.14% | 0.51% | 1.09% | 2.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -68.12% | -81.73% | -65.07% | -58.76% | 333.68% |
| Change in Net Operating Assets | -348.64% | -50.10% | 53.09% | 34.50% | 61.79% |
| Cash from Operations | -7.47% | -3.54% | 32.14% | 22.23% | 35.25% |
| Capital Expenditure | -7.65% | 14.55% | 12.76% | 10.15% | 10.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 77.89% | 89.37% | 79.38% | 76.96% | -320.14% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -265.10% | -227.20% | -222.54% | -104.12% | 462.50% |
| Cash from Investing | -38.97% | 19.44% | 0.12% | 54.55% | -52.27% |
| Total Debt Issued | -- | 346,300.00% | 74.95% | 74.95% | 74.95% |
| Total Debt Repaid | 9.24% | 8.97% | 53.91% | -65.87% | 12.44% |
| Issuance of Common Stock | -3.32% | 99.64% | 111.54% | 87.90% | 81.90% |
| Repurchase of Common Stock | -67.13% | -114.95% | -100.74% | -48.00% | -15.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.17% | -2.42% | -2.64% | -2.82% | -2.86% |
| Other Financing Activities | -56.58% | -58.80% | -40.30% | -30.27% | -1.08% |
| Cash from Financing | -125.60% | 37.84% | 40.68% | -8.23% | 33.01% |
| Foreign Exchange rate Adjustments | 330.00% | -38.46% | 3,950.00% | -111.54% | -170.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -162.14% | 442.90% | 180.90% | 1,571.56% | 480.39% |